A factor secreted by a human pulmonary alveolar epithelial-like cell line blocks T-cell proliferation between G1 and S phase.
暂无分享,去创建一个
C. Mody | L. Turka | A. Chavis | G. Toews | R. Paine | P. Christensen | D. Gaposchkin | P. J. Christensen | Laurence A. Turka | Christopher H. Mody | Anthony Chavis | Daniel P. Gaposchkin
[1] C. Mody,et al. Alveolar epithelial cells block lymphocyte proliferation in vitro without inhibiting activation. , 1991, American journal of respiratory cell and molecular biology.
[2] L. Mayer,et al. Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. , 1991, American journal of respiratory cell and molecular biology.
[3] C. Thompson,et al. Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine. , 1991, The Journal of clinical investigation.
[4] Z. Toossi,et al. Requirement for cell-to-cell contact for the immunosuppressive activity of human alveolar macrophages. , 1991, American journal of respiratory cell and molecular biology.
[5] C. Thompson,et al. Guanine ribonucleotide depletion inhibits T cell activation. , 1991, Advances in experimental medicine and biology.
[6] T. Standiford,et al. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. , 1990, The Journal of clinical investigation.
[7] M. Peters-Golden,et al. Arachidonate metabolism increases as rat alveolar type II cells differentiate in vitro. , 1990, The American journal of physiology.
[8] H. Weiner,et al. Characterization of immunomodulatory properties and accessory cell function of small intestinal epithelial cells. , 1990, Cellular immunology.
[9] C. Thompson,et al. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes. , 1990, Journal of immunology.
[10] J. Lacy,et al. Rat tracheal epithelial cells produce granulocyte/macrophage colony-stimulating factor. , 1990, American journal of respiratory cell and molecular biology.
[11] J. Siegfried. Culture of primary lung tumors using medium conditioned by a lung carcinoma cell line , 1989, Journal of cellular biochemistry.
[12] G. Crabtree. Contingent genetic regulatory events in T lymphocyte activation. , 1989, Science.
[13] M. Jenkins,et al. Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones. , 1988, Journal of immunology.
[14] R. Crystal,et al. T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1. , 1988, Clinical immunology and immunopathology.
[15] Ralb. The normal lung. , 1987 .
[16] M. Sporn,et al. Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.
[17] K. Nishioka,et al. Ia antigen expressed by keratinocytes can be the molecule of antigen presentation in contact sensitivity. , 1987, The Journal of investigative dermatology.
[18] M. Sporn,et al. Transforming growth factor-beta: biological function and chemical structure. , 1986, Science.
[19] R. Crystal,et al. Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset. , 1986, The Journal of clinical investigation.
[20] P. Bland,et al. Antigen presentation by epithelial cells of the rat small intestine. I. Kinetics, antigen specificity and blocking by anti-Ia antisera. , 1986, Immunology.
[21] P. Bland,et al. Antigen presentation by epithelial cells of the rat small intestine. II. Selective induction of suppressor T cells. , 1986, Immunology.
[22] M. Sporn,et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth , 1986, The Journal of experimental medicine.
[23] P. Golstein,et al. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester , 1985, Nature.
[24] R. G. Sitrin,et al. The effect of pulmonary surface-active material on the generation and expression of murine B- and T-lymphocyte effector functions in vitro. , 1985, Experimental lung research.
[25] J. Uhr,et al. Antigen presentation by guinea pig alveolar macrophages. , 1981, Journal of immunology.
[26] B. Benson,et al. Identification of the immunosuppressive components of canine pulmonary surface active material. , 1980, Journal of immunology.
[27] P. Holt. Alveolar macrophages. IV. Interspecies differences in activity in proliferating lymphocyte cultures. , 1980, Cellular immunology.
[28] M. Williams,et al. Phospholipid composition and ultrastructure of A549 cells and other cultured pulmonary epithelial cells of presumed type II cell origin. , 1980, Biochimica et biophysica acta.
[29] V. Ferrans,et al. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. , 1979, The American journal of pathology.
[30] B. Benson,et al. Immunosuppressive activity of canine pulmonary surface active material. , 1979, Journal of immunology.
[31] B. Smith. Cell line A549: a model system for the study of alveolar type II cell function. , 1977, The American review of respiratory disease.
[32] J. Bienenstock,et al. Lung defense mechanisms (second of two parts). , 1976, The New England journal of medicine.
[33] J. Bienenstock,et al. Lung defense mechanisms (first of two parts). , 1976, The New England journal of medicine.
[34] Barry H. Smith,et al. A continuous tumor‐cell line from a human lung carcinoma with properties of type II alveolar epithelial cells , 1976, International journal of cancer.
[35] M. Altose,et al. Immunocompetent cells from the lower respiratory tract of normal human lungs. , 1975, The Journal of clinical investigation.